v3.26.3
Consolidated Statements of Cash Flows - CAD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating Activities    
Net loss for the period $ (44,214,333) $ (23,664,711)
Items not involving cash:    
Amortization of intangible asset (Note 13) 55,795 55,795
Depreciation expense (Note 11, 12)   28,003
Interest expense on lease liability (Note 12) 3,691 9,340
Interest income on net investment in lease (Note 12) (3,691) (6,369)
Stock-based compensation (Note 15, 18) 3,603,619 4,529,991
Unrealized foreign exchange (452,133) 294,338
Change in fair value of warrant derivative (Note 16) 20,850,381 1,060,353
Loss on derecognition of equipment (Note 11)   6,851
Net investment in sub-sublease (Note 12)   6,819
Changes in non-cash working capital:    
Receivables (Note 10) 334,476 (165,092)
Prepaid expenses (Note 9, 17) 591,223 (223,735)
Accounts payable and accrued liabilities (Note 14, 15) (268,239) 1,227,383
Cash flows from operating activities (19,499,211) (16,841,034)
Investing Activities    
Payments received from net investment in lease (Note 12) 100,926 58,874
Cash flows from investing activities 100,926 58,874
Financing Activities    
Repayment of lease liability (Note 12) (100,926) (100,926)
Gross proceeds from issuance of common shares (Note 16, 17) 16,884,659 23,011,788
Share issue costs - cash (Note 17) (892,783) (1,630,342)
Warrant and option exercises (Note 18) 7,872,987 1,414,591
Cash flows from financing activities 23,763,937 22,695,111
Effect of foreign exchange on cash and cash equivalents 436,494 (305,006)
Net (decrease) increase in cash and cash equivalents 4,802,146 5,607,945
Cash and cash equivalents, beginning of period 17,267,489 11,659,544
Cash and cash equivalents, end of period 22,069,635 17,267,489
Non-cash transactions:    
Finder's/Broker's warrants   138,603
Fair value of options allocated to share capital 3,141,032 856,540
Fair value of warrants allocated to share capital $ 322,058 $ 18,250